Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain.
Pentixapharm Acquires Target Discovery Business of Glycotope – Biotech Investments
EQS-News: Pentixapharm AG / Key word(s): Takeover Pentixapharm Acquires Target Discovery Business of Glycotope 03.07.2024 / 08:30 CET/CEST The issuer is solely responsible for the